Format

Send to

Choose Destination
Ann Oncol. 2017 Jan 1;28(1):183. doi: 10.1093/annonc/mdw448.

Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck?

Author information

1
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
2
Clinical Pharmacokinetics, La Timone University Hospital, Marseille, and GPCO-Unicancer, Paris, France.
3
Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
4
Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart and Department of Clinical Pharmacology, University Hospital, Tuebingen, Germany.
5
IFCC Reference center - Pharmacogenetics, Department of Clinical Chemistry, Erasmus University, Rotterdam.
6
Department of Clinical Chemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
PMID:
27687313
DOI:
10.1093/annonc/mdw448
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center